In searching for other SRRM4-targeted RNA splicing that may contribute to NEPC progression, we have found a highly expressed splice variant of the MYST/Esa1-associated factor 6 (MEAF6) gene, MEAF6-1, in NEPC tumor samples. Here, SRRM4 is linked to neoplasm.